Published in Biomark Med on April 01, 2011
Natural diterpenes from coffee, cafestol and kahweol induce apoptosis through regulation of specificity protein 1 expression in human malignant pleural mesothelioma. J Biomed Sci (2012) 0.95
Diagnostic values of soluble mesothelin-related peptides for malignant pleural mesothelioma: updated meta-analysis. BMJ Open (2014) 0.90
Combined serum mesothelin and carcinoembryonic antigen measurement in the diagnosis of malignant mesothelioma. Mol Clin Oncol (2013) 0.86
New high affinity monoclonal antibodies recognize non-overlapping epitopes on mesothelin for monitoring and treating mesothelioma. Sci Rep (2015) 0.81
Systematic analysis and validation of differential gene expression in ovarian serous adenocarcinomas and normal ovary. J Cancer Res Clin Oncol (2012) 0.77
Chemokine (C-C motif) ligand 3 detection in the serum of persons exposed to asbestos: A patient-based study. Cancer Sci (2015) 0.77
A Novel Panel of Serum Biomarkers for MPM Diagnosis. Dis Markers (2017) 0.75
SV40 enhances the risk of malignant mesothelioma among people exposed to asbestos: a molecular epidemiologic case-control study. Cancer Res (2005) 1.75
Clinical significance of serum mesothelin in patients with mesothelioma and lung cancer. Clin Cancer Res (2007) 1.24
Combined serum mesothelin and plasma osteopontin measurements in malignant pleural mesothelioma. J Thorac Oncol (2011) 0.93
A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma. Mutat Res (2011) 0.93
Comparison between plasma and serum osteopontin levels: usefulness in diagnosis of epithelial malignant pleural mesothelioma. Int J Biol Markers (2010) 0.91
Polymorphism of the 3'-untranslated region of the leptin receptor gene, but not the adiponectin SNP45 polymorphism, predicts type 2 diabetes: a population-based study. Diabetes Care (2006) 0.86
Risk of differentiated thyroid carcinoma and polymorphisms within the susceptibility cancer region 8q24. Cancer Epidemiol Biomarkers Prev (2013) 0.82
Polymorphisms in the putative micro-RNA-binding sites of mesothelin gene are associated with serum levels of mesothelin-related protein. Occup Environ Med (2009) 0.81
Comparative proteomic analysis of malignant pleural mesothelioma evidences an altered expression of nuclear lamin and filament-related proteins. Proteomics Clin Appl (2014) 0.80
A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people. J Thorac Oncol (2014) 0.79
TPO genetic variants and risk of differentiated thyroid carcinoma in two European populations. Int J Cancer (2013) 0.79
Rosiglitazone increases matrix production and quenches inflammation: studies in human cells. Diabetes Metab Res Rev (2008) 0.77
Two novel polymorphisms in 5' flanking region of the mesothelin gene are associated with soluble mesothelin-related peptide (SMRP) levels. Int J Biol Markers (2011) 0.77
Thyroid hormone receptor and IGF1/IGFR systems: possible relations in the human heart. Biomed Pharmacother (2007) 0.75
Identification of active siRNAs against IGF-IR of porcine coronary smooth muscle cells in a heterologous cell line. Int J Mol Med (2005) 0.75
Correction: MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma. PLoS One (2017) 0.75